z-logo
open-access-imgOpen Access
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
Author(s) -
Awadh Kishor Pandit,
Kameshwar Prasad,
Tulika Seth
Publication year - 2015
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.165482
Subject(s) - medicine , multiple sclerosis , hematopoietic stem cell transplantation , stem cell , transplantation , mitoxantrone , stem cell therapy , population , oncology , surgery , immunology , chemotherapy , environmental health , biology , genetics
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell transplantation seems to be promising in recent literature. The current case report is a novel evidence for autologous hematopoietic stem cell transplantation (HSCT) in progressive MS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here